Phase II Efficacy and Safety of 80 Mg Osimertinib in Patients with Leptomeningeal Metastases Associated with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer (BLOSSOM)

Sehhoon Park, Richard Baldry,Hyun Ae Jung,Jong-Mu Sun,Se-Hoon Lee,Jin Seok Ahn,Yu Jung Kim,Youngjoo Lee,Dong-Wan Kim,Sang-We Kim,Ki Hyeong Lee,Won Jae Lee,Jung Won Choi,Kyuha Chong,Jung-Il Lee, So-Hyeon Gwon,Nak-Hoon Son,Myung-Ju Ahn

JOURNAL OF CLINICAL ONCOLOGY（2024）

Cited 0|Views16
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined